Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrointestinal Behavior of Posaconazol in Healthy Volunteers
NCT02048345Phase 1Unknown
- Sponsor
- KU Leuven
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of posaconazole in fungal infection (4 arms), sponsored by KU Leuven. Primary endpoint: Concentration-time profile in stomach and small intestine at 48 hours. Status: unknown.
02
Drugs
posaconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT02048345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048345.